- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 4 - Pushing Reform through Immunotherapy
As the panelists explore the costs and value of genomic precision therapy and immunotherapy, Michael Kolodziej, MD, explains that multiple factors should be considered when determining the cost of care for a cancer patient. For instance, he believes that 30% of total healthcare costs for cancer patients is wastefully spent.
While curative immunotherapy is still not quite on the table, clinicians have already witnessed a “plateau of survival” for melanoma patients treated with ipilimumab, as explained by Jeffrey Weber, MD, PhD.
Dr Weber agrees that wasteful spending is a concern, and as he explains that survival is the ultimate goal for cancer treatment, he and Dr Kolodziej conclude that reimbursement models need to be addressed to eliminate wasteful spending, identify value, and provide meaningful outcomes.
Trends in Hospital Pricing for Vulnerable Emergency Department Users, 2021-2023
December 4th 2025Self-pay emergency department prices rose significantly from 2021 to 2023, especially at for-profit and system-affiliated hospitals, highlighting growing affordability challenges for uninsured and underinsured patients.
Read More
